Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels

Neurocritical Care

Volumn 14, Issue 2, 2011, Pages 194-199

  Da Silva Gullo, Jackson ^a   Bertotti, Melina Moré ^b   Silva, Cláudia Carvalho Pestana ^a   Schwarzbold, Marcelo ^a   Diaz, Alexandre Paim ^a   Soares, Flávia Mahatma Schneider ^a   Freitas, Fernando Cini ^a,b   Nunes, Jean ^a   Pinheiro, José Tadeu ^a   Morato, Edelton Flavio ^a   Prediger, Rui Daniel ^a   Linhares, Marcelo Neves ^a,b   Walz, Roger ^a,b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b HOSPITAL GOVERNADOR CELSO RAMOS   (Brazil)

Author keywords

Prognosis; Serum PTX3 levels; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; PENTRAXIN 3;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INJURY SEVERITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN INJURIES; C-REACTIVE PROTEIN; FEMALE; GLASGOW COMA SCALE; HOSPITAL MORTALITY; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; SERUM AMYLOID P-COMPONENT; YOUNG ADULT;

EID: 79955818102     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9462-y     Document Type: Article

References (25)

1. Marshall LF, Becker DP, Bowers SA, et al. The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neurosurg. 1983;59:276-84. (Pubitemid 13029207)
2. Marshall LF, Toole BM, Bowers SA. The National Traumatic Coma Data Bank. Part 2: Patients who talk and deteriorate: implications for treatment. J Neurosurg. 1983;59:285-8. (Pubitemid 13029208)
3. Martins ET, Linhares MN, Sousa DS, Schroeder HK, Meinerz J, Bertotti MM, Gullo J, Hohl A, Dal-Pizzol F, Walz R. Mortality in severe traumatic brain injury: a multivariated analysis of 748 patients from Florianópolis city. J Trauma. 2009;67(1):85-90.
4. Koizumi MS, Lebrao ML, Mello-Jorge MH, Primerano V. Morbidity and mortality due to traumatic brain injury in Sao Paulo City, Brazil, 1997. Arq Neuropsiquiatr. 2000;58:81-9.
5. Perel P, Edwards P, Wentz R, Roberts I. Systematic review of prognostic models in traumatic brain injury. BMC Med Inform Decis Mak. 2006;6:38.
6. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728-41. (Pubitemid 351957931)
7. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348:1365-75. (Pubitemid 36384105)
8. Graham DP, Cardon AL. An update on substance use and treatment following traumatic brain injury. Ann N Y Acad Sci. 2008; 1141:148-62.
9. Schwarzbold ML, Rial D, De Bem T, Machado DG, Cunha MP, dos Santos AA, dos Santos DB, Figueiredo CP, Farina M, Goldfeder EM, Rodrigues ALS, Prediger RDS, Walz R. Effects of traumatic brain injury of different severities on emotional, cognitive, and oxidative stress-related parameters in mice. J Neurotrauma. 2010;27(10):1883-93.
10. Spaethling JM, Geddes-Klein DM, Miller WJ, et al. Linking impact to cellular and molecular sequelae of CNS injury: modeling in vivo complexity with in vitro simplicity. Prog Brain Res. 2007;161:27-39. (Pubitemid 47017398)
11. Brugger-Andersen T, Ponitz V, Kontny F, et al. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thromb Haemost. 2009;102(3):555-63.
12. Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157-83.
13. Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty, Bruce M. Associations of pentraxin 3 with cardiovascular disease and allcause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2009;29(4):594-9.
14. Ortega-Hernandez OD, Bassi N, Shoenfeld Y, Anaya JM. The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum. 2009;39(1):38-54.
15. Reid MS, Blobel CP. Apexin, an acrosomal pentaxin. J Biol Chem. 1994;269(51):32615-20.
16. Noland TD, Friday BB, Maulit MT, Gerton GL. The sperm acrosomal matrix contains a novel member of the pentaxin family of calcium-dependent binding proteins. J Biol Chem. 1994; 269(51):32607-14.
17. Schlimgen AK, Helms JA, Vogel H, Perin MS. Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system. Neuron. 1995;14(3):519-26.
18. Hsu YC, Perin M. Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization. Genomics. 1995;28(2):220-7.
19. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C, Worley PF. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J Neurosci. 1996;16(8):2463-78. (Pubitemid 26122671)
20. Kirkpatrick LL, Matzuk MM, Dodds DC, Perin MS. Biochemical interactions of the neuronal pentraxins. Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. J Biol Chem. 2000;275(23): 17786-92. (Pubitemid 30430829)
21. Polentarutti N, Bottazzi B, Di Santo E, et al. Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol. 2000;106(1-2):87-94. (Pubitemid 30256081)
22. Ravizza T, Moneta D, Bottazzi B, et al. Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience. 2001;105(1):43-53. (Pubitemid 32722092)
23. Marshall LF, Marshall SB, Klauber MR, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9(Suppl 1):287-92.
24. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316:1236-8. (Pubitemid 28171344)
25. Murray GD, Butcher I, McHugh GS, et al. Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24:329-37. (Pubitemid 46492154)